NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Thursday that its second quarter revenues climbed 7 percent year over year.

The Santa Clara, Calif.-based microarray firm said that for the three months ended June 30, total revenues increased to $85.4 million from $79.5 million a year ago, beating the average Wall Street estimate of $83.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.